Kaiser L et al. |
Dirofilaria immitis: do filarial cyclooxygenase products depress endothelium-dependent relaxation in the in vitro rat aorta? |
1992 |
Exp. Parasitol. |
pmid:1516664
|
Yuan Z et al. |
Peroxisome proliferator-activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis associated with inhibition of self-sensitive T cells. |
2004 |
J. Cardiovasc. Pharmacol. |
pmid:15167281
|
Dahlén SE and Kumlin M |
Monitoring mast cell activation by prostaglandin D2 in vivo. |
2004 |
Thorax |
pmid:15170020
|
Bochenek G et al. |
Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma. |
2004 |
Thorax |
pmid:15170023
|
Rodway HA et al. |
Lysophosphatidic acid attenuates the cytotoxic effects and degree of peroxisome proliferator-activated receptor gamma activation induced by 15-deoxyDelta12,14-prostaglandin J2 in neuroblastoma cells. |
2004 |
Biochem. J. |
pmid:15171682
|
Hawcroft G et al. |
Expression of prostaglandin D2 receptors DP1 and DP2 by human colorectal cancer cells. |
2004 |
Cancer Lett. |
pmid:15172124
|
Son DJ et al. |
Antiplatelet effect of green tea catechins: a possible mechanism through arachidonic acid pathway. |
2004 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:15172681
|
Takeshita K et al. |
CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation. |
2004 |
Int. Immunol. |
pmid:15173122
|
Cheron A et al. |
15-deoxy-Delta12,14-prostaglandin J2 inhibits glucocorticoid binding and signaling in macrophages through a peroxisome proliferator-activated receptor gamma-independent process. |
2004 |
J. Immunol. |
pmid:15187150
|
Siavash H et al. |
Targeting of epidermal growth factor receptor by cyclopentenone prostaglandin 15-Deoxy-Delta12,14-prostaglandin J2 in human oral squamous carcinoma cells. |
2004 |
Cancer Lett. |
pmid:15194221
|
Li Z et al. |
Delta12-Prostaglandin J2 inhibits the ubiquitin hydrolase UCH-L1 and elicits ubiquitin-protein aggregation without proteasome inhibition. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15194490
|
Ruiz PA et al. |
15-deoxy-delta12,14-prostaglandin J2-mediated ERK signaling inhibits gram-negative bacteria-induced RelA phosphorylation and interleukin-6 gene expression in intestinal epithelial cells through modulation of protein phosphatase 2A activity. |
2004 |
J. Biol. Chem. |
pmid:15199053
|
Shimomura K et al. |
Fenofibrate, troglitazone, and 15-deoxy-Delta12,14-prostaglandin J2 close KATP channels and induce insulin secretion. |
2004 |
J. Pharmacol. Exp. Ther. |
pmid:15201343
|
Park KS et al. |
Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway. |
2004 |
Exp. Cell Res. |
pmid:15212945
|
Shan ZZ et al. |
A potential role of 15-deoxy-delta(12,14)-prostaglandin J2 for induction of human articular chondrocyte apoptosis in arthritis. |
2004 |
J. Biol. Chem. |
pmid:15213234
|
Krueger JM et al. |
Prostaglandins E2 and D2 have little effect on rabbit sleep. |
1992 |
Physiol. Behav. |
pmid:1523224
|
Azuma Y et al. |
Induction of proliferation by 15-deoxy-delta12,14-prostaglandin J2 and the precursors in monocytic leukemia U937. |
2004 |
Pharmacology |
pmid:15240994
|
Zhang C et al. |
The novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in Mycosis fungoides/Sézary syndrome cells. |
2004 |
J. Invest. Dermatol. |
pmid:15245439
|
Fernández-Tome M et al. |
p44/42(ERK1/2) MAPK and PLD activation by PGD2 preserves papillary phosphatidylcholine homeostasis. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15249196
|
Kanunfre CC et al. |
Ciglitizone and 15d PGJ2 induce apoptosis in Jurkat and Raji cells. |
2004 |
Int. Immunopharmacol. |
pmid:15251113
|
Berry EB et al. |
Differential effects of serum constituents on apoptosis induced by the cyclopentenone prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in WISH epithelial cells. |
2004 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:15253890
|
Morosetti R et al. |
The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines. |
2004 |
Int. J. Oncol. |
pmid:15254749
|
Tanaka Y et al. |
Enhanced release of prostaglandin D2 during re-incubation of RAW 264.7 macrophage-like cells after treatment of both lipopolysaccharide and non-steroidal anti-inflammatory drugs. |
2004 |
Biol. Pharm. Bull. |
pmid:15256727
|
Jawerbaum A et al. |
Influence of peroxisome proliferator-activated receptor gamma activation by its endogenous ligand 15-deoxy Delta12,14 prostaglandin J2 on nitric oxide production in term placental tissues from diabetic women. |
2004 |
Mol. Hum. Reprod. |
pmid:15258247
|
Zhao ML et al. |
15-deoxy-delta (12,14)-PGJ2 inhibits astrocyte IL-1 signaling: inhibition of NF-kappaB and MAP kinase pathways and suppression of cytokine and chemokine expression. |
2004 |
J. Neuroimmunol. |
pmid:15265671
|
Zhang X et al. |
Peroxisome proliferator-activated receptor-gamma and its ligands attenuate biologic functions of human natural killer cells. |
2004 |
Blood |
pmid:15265789
|
Hofnagel O et al. |
Proinflammatory cytokines regulate LOX-1 expression in vascular smooth muscle cells. |
2004 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:15271788
|
Eguchi N et al. |
Permeability of brain structures and other peripheral tissues to prostaglandins D2, E2 and F2 alpha in rats. |
1992 |
J. Pharmacol. Exp. Ther. |
pmid:1527717
|
Grau R et al. |
Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism. |
2004 |
Cancer Res. |
pmid:15289320
|
Yoshimura-Uchiyama C et al. |
Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2. |
2004 |
Clin. Exp. Allergy |
pmid:15298571
|
Servidei T et al. |
The cellular response to PPARgamma ligands is related to the phenotype of neuroblastoma cell lines. |
2004 |
Oncol. Res. |
pmid:15301425
|
Boyault S et al. |
15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-1beta-induced IKK enzymatic activity and IkappaBalpha degradation in rat chondrocytes through a PPARgamma-independent pathway. |
2004 |
FEBS Lett. |
pmid:15304320
|
Kielian T et al. |
S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2). |
2004 |
J. Neurochem. |
pmid:15312171
|
Weber SM et al. |
PPARgamma ligands induce ER stress in pancreatic beta-cells: ER stress activation results in attenuation of cytokine signaling. |
2004 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:15315910
|
Szczeklik W et al. |
Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. |
2004 |
J. Allergy Clin. Immunol. |
pmid:15316498
|
Siavash H et al. |
Abrogation of IL-6-mediated JAK signalling by the cyclopentenone prostaglandin 15d-PGJ(2) in oral squamous carcinoma cells. |
2004 |
Br. J. Cancer |
pmid:15316561
|
Sánchez-Gómez FJ et al. |
Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes. |
2004 |
Mol. Pharmacol. |
pmid:15317873
|
Sinzinger H et al. |
Isradipine improves platelet function in hypertensives. |
1992 |
Eur. J. Clin. Pharmacol. |
pmid:1531796
|
Shahab R et al. |
Prostaglandins, leukotrienes and perennial rhinitis. |
2004 |
J Laryngol Otol |
pmid:15318955
|
Lim SY et al. |
15-Deoxy-Delta12,14-prostaglandin J(2) protects against nitrosative PC12 cell death through up-regulation of intracellular glutathione synthesis. |
2004 |
J. Biol. Chem. |
pmid:15319433
|
Sasaguri T and Miwa Y |
Prostaglandin J2 family and the cardiovascular system. |
2004 |
Curr Vasc Pharmacol |
pmid:15320511
|
Schlezinger JJ et al. |
Environmental and endogenous peroxisome proliferator-activated receptor gamma agonists induce bone marrow B cell growth arrest and apoptosis: interactions between mono(2-ethylhexyl)phthalate, 9-cis-retinoic acid, and 15-deoxy-Delta12,14-prostaglandin J2. |
2004 |
J. Immunol. |
pmid:15322177
|
Si Q et al. |
15-deoxy-Delta12,14-prostaglandin J2 inhibits IFN-inducible protein 10/CXC chemokine ligand 10 expression in human microglia: mechanisms and implications. |
2004 |
J. Immunol. |
pmid:15322215
|
Cheng J et al. |
Peroxisome proliferator-activated receptor gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15325252
|
Li L et al. |
Molecular mechanisms regulating the antifibrogenic protein heme-oxygenase-1 in human hepatic myofibroblasts. |
2004 |
J. Hepatol. |
pmid:15336443
|
Hirata Y et al. |
Anti-apoptotic and pro-apoptotic effect of NEPP11 on manganese-induced apoptosis and JNK pathway activation in PC12 cells. |
2004 |
Brain Res. |
pmid:15342272
|
Luster AD and Tager AM |
T-cell trafficking in asthma: lipid mediators grease the way. |
2004 |
Nat. Rev. Immunol. |
pmid:15343370
|
Atkins KB et al. |
Effects of PPAR-gamma ligands on vascular smooth muscle marker expression in hypertensive and normal arteries. |
2005 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:15345487
|
Magnussen H et al. |
Effects of a thromboxane-receptor antagonist, BAY u 3405, on prostaglandin D2- and exercise-induced bronchoconstriction. |
1992 |
J. Allergy Clin. Immunol. |
pmid:1535083
|
Ehara N et al. |
Activators of PPARgamma antagonize protection of cardiac myocytes by endothelin-1. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15358182
|